Vaccines and Related Biological Products Advisory Committee
March 10, 2000 Meeting
Important Notice
The meeting of the Vaccines and Related Biological Products Advisory Committee, scheduled for March 9 and 10 at the Holiday Inn, Silver Spring, has been scaled back.
The meeting will now be held only on Friday, March 10, beginning at 12 noon. The advisory committee will participate from their various institutions by teleconference. Because this is an open meeting, the teleconference will originate at the Holiday Inn, Silver Spring so that the public can attend at the hotel.
The agenda has been scaled back to two topics: the completion of formulation of the influenza virus vaccine for the 2000-2001 season, and a briefing on the vaccine safety action plan. Open public hearings are included in the agenda.
Questions should be directed to the meeting contacts, Nancy Cherry or Denise Royster, on 301-827-0314.
Agenda - Meeting by Teleconference
Friday, March 10, 2000
Holiday Inn, 8777 Georgia Avenue
Silver Spring, Maryland
Noon Teleconference Roll Call; Call to Order, Introductions, Administrative Matters
12:15 Session 1 - Open Session
12:15 Review of Current Situation
Dr. Roland Levandowski, FDA
12:25 Additional Information on Strain Surveillance and Epidemiology
Dr. Nancy Cox, CDC
12:40 Additional Information on SerologicResults and Reference Strains
Dr. Roland Levandowski
12:55 Options for Strain Selection
Dr. Roland Levandowski
1:05 Open Public Hearing
1:15 Committee Discussion and Voting
2:15 Session 2 - Open Session
2:15 Briefing
Dr. William Egan, FDA
2:45 Open Public Hearing
3:45 Adjournment
|
